Related Experiment Video
Updated: Jun 25, 2025
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
A Novel NUTM1-NSMCE2 Fusion Gene in a Pediatric Chest NUT Carcinoma
Francesco De Leonardis1, Vittorio Greco Miani1, Silvia Vallese2
1Division of Paediatric Haematology-Oncology, University Hospital of Bari.
Abstract:
Nuclear protein of the testis carcinoma is an exceedingly rare and poorly differentiated carcinoma characterized by BDR4::NUTM1 gene translocation. Typically, the tumor affects young adults, and no standardized recommendations for therapeutic management have been available since 2022; the clinical course remains mostly dismal. We report the successful multimodal treatment of a 13-year-old boy affected by a primary chest NUT-carcinoma with a novel NUTM1 rearrangement that remains in complete continuous remission at 30 months from diagnosis.
Insights
Nuclear protein in testis (NUT) carcinoma is a rare cancer in young adults. Multimodal treatment led to a 30-month remission in a 13-year-old boy with a novel NUTM1 rearrangement.
Area of Science:
- Oncology
- Genetics
- Pediatric Cancer
Background:
- Nuclear protein in testis (NUT) carcinoma is a rare, aggressive cancer.
- Characterized by specific gene translocations like BDR4::NUTM1.
- Affects primarily young adults with limited treatment guidelines and poor prognosis.
Purpose of the Study:
- To report a successful multimodal treatment strategy.
- To highlight a novel NUTM1 gene rearrangement.
- To demonstrate long-term remission in a pediatric patient.
Main Methods:
- Diagnosis of primary chest NUT carcinoma in a 13-year-old male.
- Identification of a novel NUTM1 rearrangement.
- Application of a multimodal treatment approach.
Main Results:
- Complete and continuous remission achieved at 30 months post-diagnosis.
- Successful management of a rare pediatric NUT carcinoma case.
- Demonstration of efficacy for the novel NUTM1 rearrangement treatment.
Conclusions:
- Multimodal therapy can be effective for pediatric NUT carcinoma.
- Novel gene rearrangements may be targetable with tailored treatments.
- Long-term remission is achievable, offering hope for similar rare cancer cases.
